GFN 2016 Announced - Evidence, Accountability, Transparency

gfn generic 100Welcome to the website for the Global Forum on Nicotine 2016. This is the third conference in the series and will again be held at the Marriott Hotel, in Warsaw, on Friday 17th and Saturday 18th June 2016.

We invite politicians, regulators, academics and researchers, public health professionals, consumers and advocates with an interest in nicotine and its uses to join us for two days packed with quality content.

Following the excellent presentations and discussions at this year’s event - which had the strapline ‘a different kind of endgame’ – next year the agenda will be crafted to address 3 key issues: Evidence, Accountability and Transparency. The conference archive for GFN15 can be found here.

It is evident that the positions on nicotine and its uses are still very polarised. In this climate a transparent approach is often difficult to achieve. Evidence should be presented and honestly evaluated, and those involved should be accountable for their conduct.

GFN16 will use its position as the only place where science and policy meet to address this problem, encouraging all stakeholders to hold rigorous and honest debates on a wide range of topics, to both inform and influence policy and practice in the future.

The programme for GFN16 will follow the pattern set by previous events. There will be a mixture of plenary, parallel, workshop and satellite sessions, as well as plenty of opportunities to network informally, including during the pre-conference social event and vapemeet.

The programme committee is still being assembled, but we would like to invite suggestions for topics, or specific presentations for inclusion in the agenda for next June. You can make suggestions via Twitter, using the hashtag #GFN16, or e-mail us at This email address is being protected from spambots. You need JavaScript enabled to view it.. The committee will begin its work early in the autumn, so you have plenty of time. To date we have had a number of suggestions, including:

  • use of e-cigarettes in mental health facilities
  • do vape shops have a role as ‘smoking cessation services’?
  • how do we ensure accountability in public health?
  • what is industry’s role in the vape market?
  • what are the characteristics of nicotine addiction?
  • implications of the implementation of the EU TPD and issues for FCTC COP7

Just a few initial ideas. The committee will begin its work early in the autumn, so you have plenty of time.

In due course we will announce who will deliver the Michael Russell Oration 2016. You can watch this year’s oration, delivered by Professor Derek Yach, here.

Registration will open in September and we will announce this through an alert and via the Nicotine Science and Policy Daily. If you are not registered to receive these, you can register here. The service is free and provides lots of useful information from the media, along with science updates, blogs and other opinion pieces.

In October we will be seeking nominations for the conference awards, including the Young Investigator Award and the Vaping Advocate of the Year Awards. Details will be posted on the site and again an alert will be sent when this happens.

We look forward to seeing you again in Warsaw!